Roper Technologies, Inc. (ROP) will report second quarter earnings on April 23, 2026. Wall Street expects $4.97 earnings per share and $2.06 billion in revenue. The industrial machinery company has beaten earnings estimates in three of the last four quarters, showing consistent execution. ROP stock trades at $362.93 with a 25.54 P/E ratio, reflecting investor confidence in the diversified software and engineered products portfolio. Understanding what analysts anticipate helps investors prepare for potential market moves.
Earnings Estimates and Historical Performance
Analysts project ROP will deliver $4.97 per share in earnings, slightly below the $5.14 EPS estimated for the previous quarter. Revenue guidance sits at $2.06 billion, down from the $2.08 billion estimate in the prior period. However, ROP’s track record tells a different story.
Recent Beat Pattern
ROP has beaten EPS estimates in three consecutive quarters. The most recent quarter delivered $5.21 actual EPS versus $5.14 estimated, a 0.07 beat. The quarter before that showed $5.14 actual versus $5.11 estimated. This consistent outperformance suggests management executes well and provides conservative guidance. Revenue beats have been mixed, with the company missing slightly in Q1 2026 but beating in Q3 2025.
Trend Analysis
Earnings per share has remained stable around $4.87 to $5.21 over the last four quarters, indicating steady profitability. Revenue has grown from $1.88 billion to $2.06 billion estimated, reflecting 9.6% sequential growth. This upward trajectory suggests the company is gaining momentum in its software and industrial segments.
What Investors Should Watch
ROP operates across software, engineered products, and industrial solutions. Investors should focus on segment performance and margin expansion as key indicators of health.
Software Segment Growth
The software division drives higher margins and recurring revenue. Watch for cloud-based software adoption rates, particularly in property and casualty insurance, foodservice operations, and healthcare. Management commentary on software bookings and retention rates will signal future revenue quality.
Margin Performance
ROP’s gross margin stands at 69.2% trailing twelve months, while operating margin is 28.3%. Investors should monitor whether the company maintains these levels amid inflation and supply chain pressures. Free cash flow of $23.25 per share demonstrates strong cash generation, crucial for funding acquisitions and dividends.
Guidance and Outlook
Management guidance for Q3 and full-year 2026 will be critical. Any commentary on economic slowdown, customer spending patterns, or acquisition integration will move the stock. ROP has a history of strategic acquisitions, so watch for M&A announcements or pipeline updates.
Valuation and Technical Setup
ROP trades at a 25.54 P/E ratio, above the S&P 500 average, reflecting its quality and growth profile. The stock has declined 32.7% over the past year, creating potential value for long-term investors.
Price Action and Momentum
ROP stock sits at $362.93, near its 50-day moving average of $349.69. The RSI indicator reads 55.91, suggesting neutral momentum with room to move in either direction. The stock’s 52-week range spans $313.07 to $584.03, showing significant volatility. Recent price action has been positive, with the stock up 0.85% today and 2.62% over the past month.
Analyst Consensus
Wall Street maintains a “Buy” consensus with 6 buy ratings, 2 strong buys, 1 hold, and 1 sell. This overwhelmingly bullish view reflects confidence in ROP’s business model and earnings power. The company’s $37.36 billion market cap and 102.9 million shares outstanding provide liquidity for institutional investors.
Meyka AI Grade and Key Metrics
Meyka AI rates ROP with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Financial Health Indicators
ROP’s debt-to-equity ratio of 0.47 is moderate and manageable. The company maintains strong interest coverage of 6.88x, meaning it easily covers debt obligations. Return on equity of 7.8% trails peers but reflects the capital-intensive nature of the business. Free cash flow yield of 6.7% is attractive for income-focused investors.
Growth Metrics
Revenue growth of 12.3% year-over-year demonstrates solid expansion. Operating income grew 11.9%, showing operational leverage. However, net income declined 0.8% due to higher tax rates and financing costs. The company’s ability to grow revenue faster than expenses suggests improving profitability ahead.
Final Thoughts
Roper Technologies enters earnings season with strong momentum and a consistent track record of beating expectations. The $4.97 EPS and $2.06 billion revenue estimates appear achievable based on recent performance, with upside potential given three consecutive earnings beats. Investors should focus on software segment growth, margin sustainability, and management guidance for the full year. The B+ Meyka grade reflects balanced fundamentals with solid cash generation offsetting moderate valuation concerns. ROP’s diversified portfolio and recurring software revenue provide resilience, making this earnings report a key test of whether the industrial sector can maintain momentum amid economic uncertainty.
FAQs
What EPS and revenue does Wall Street expect from ROP?
Analysts expect ROP to report $4.97 earnings per share and $2.06 billion in revenue for Q2 2026. The company has beaten EPS estimates in three of the last four quarters, suggesting conservative guidance.
Has ROP beaten earnings estimates recently?
Yes. ROP beat EPS estimates in three consecutive quarters, most recently delivering $5.21 actual versus $5.14 estimated. This pattern indicates management provides conservative guidance and executes well operationally.
What should investors watch during the earnings call?
Focus on software segment growth, gross and operating margins, free cash flow trends, and management guidance. Monitor commentary on customer spending, economic conditions, and potential acquisitions driving long-term value.
What does the B+ Meyka grade mean for ROP?
The B+ grade reflects balanced fundamentals: strong cash generation, solid revenue growth, and analyst consensus support. Moderate valuation and lower ROE versus peers temper the rating, suggesting neutral positioning with upside potential.
Is ROP a good buy before earnings?
ROP trades at 25.54 P/E with strong analyst support (6 buys, 2 strong buys). The 32.7% annual decline creates value. Conduct your own research—past performance doesn’t guarantee future results.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)